All Stories

  1. Socioeconomic Deprivation and Invasive Breast Cancer Incidence by Stage at Diagnosis: A Possible Explanation to the Breast Cancer Social Paradox
  2. Multidimensional penalized splines for survival models: illustration for net survival trend analyses
  3. Cancer Survival and Travel Time to Nearest Reference Care Center for 10 Cancer Sites: An Analysis of 21 French Cancer Registries
  4. Survival after breast cancer according to participation in organised or opportunistic screening and deprivation
  5. Is the Social Gradient in Net Survival Observed in France the Result of Inequalities in Cancer-Specific Mortality or Inequalities in General Mortality?
  6. Global survival trends for brain tumors, by histology: analysis of individual records for 556,237 adults diagnosed in 59 countries during 2000–2014 (CONCORD-3)
  7. Is survival rate lower after breast cancer in deprived women according to disease stage?
  8. Cross-sectional nationwide mixed-methods population-based study of living conditions, and identification of sexual and fertility profiles among young women after breast cancer in France: the Candy study protocol
  9. Clear Improvement in Real-World Chronic Myeloid Leukemia Survival: A Comparison With Randomized Controlled Trials
  10. Care pathway of women with interval breast cancer in 2016, based on medico-administrative data
  11. Worldwide trends in population-based survival for children, adolescents, and young adults diagnosed with leukaemia, by subtype, during 2000–14 (CONCORD-3): analysis of individual data from 258 cancer registries in 61 countries
  12. Colorectal cancer among farmers in the AGRICAN cohort study
  13. To what extent do age, stage and treatment influence survival after invasive cervical cancer: a French population-based study
  14. Socioeconomic Environment and Survival in Patients with Digestive Cancers: A French Population-Based Study
  15. How do age and social environment affect the dynamics of death hazard and survival in patients with breast or gynecological cancer in France?
  16. Cancer incidence and mortality trends in France over 1990–2018 for solid tumors: the sex gap is narrowing
  17. Effects of fertility on breast cancer incidence trends: comparing France and US
  18. Flexible Modeling of Net Survival and Cure by AML Subtype and Age: A French Population-Based Study from FRANCIM
  19. What is the most appropriate period to define synchronous cancers?
  20. The histology of brain tumors for 67 331 children and 671 085 adults diagnosed in 60 countries during 2000-2014: a global, population-based study (CONCORD-3)
  21. THE AUTHORS REPLY
  22. Association of Mammography Screening With a Reduction in Breast Cancer Mortality: A Modeling Study Using Population-Based Data From 2 French Departments
  23. Evaluation of long‐term living conditions in patients treated for localised prostate cancer
  24. Endocrine treatment and incidence of relapse in women with oestrogen receptor-positive breast cancer in Europe: a population-based study
  25. Welding and the risk of head and neck cancer: the ICARE study
  26. Reasons for low cervical cancer survival in new accession European Union countries: a EUROCARE-5 study
  27. The respective parts of incidence and lethality in socioeconomic differences in cancer mortality. An analysis of the French network Cancer registries (FRANCIM) data
  28. Compliance with clinical guidelines for breast cancer management: A population-based study of quality-of-care indicators in France
  29. Trends in incidence of small bowel cancer according to histology: a population-based study
  30. Occupational exposure to wood dust and risk of lung cancer: the ICARE study
  31. Occupational exposure to pesticides and multiple myeloma in the AGRICAN cohort
  32. Agricultural exposures to carbamate herbicides and fungicides and central nervous system tumour incidence in the cohort AGRICAN
  33. Using ecological socioeconomic position (SEP) measures to deal with sample bias introduced by incomplete individual-level measures: inequalities in breast cancer stage at diagnosis as an example
  34. Épidémiologie descriptive des cancers en France métropolitaine : incidence, survie et prévalence
  35. ETIOSARC study : environmental aetiology of sarcomas from a French prospective multicentric population-based case–control study—study protocol
  36. Head and neck cancer and occupational exposure to leather dust: results from the ICARE study, a French case-control study
  37. Mise en place du programme national de dépistage organisé du cancer du col de l’utérus en France
  38. Treatment challenges in and outside a specialist network setting: Pancreatic neuroendocrine tumours
  39. Mesothelioma and thymic tumors: Treatment challenges in (outside) a network setting
  40. Testicular germ-cell tumours and penile squamous cell carcinoma: Appropriate management makes the difference
  41. Treatment challenges in and outside a network setting: Head and neck cancers
  42. Rare ovarian tumours: Epidemiology, treatment challenges in and outside a network setting
  43. Epidemiology of rare cancers and inequalities in oncologic outcomes
  44. Treatment challenges in and outside a network setting: Soft tissue sarcomas
  45. Comorbidities, age and period of diagnosis influence treatment and outcomes in early breast cancer
  46. Increased risk of central nervous system tumours with carbamate insecticide use in the prospective cohort AGRICAN
  47. Are comorbidities associated with long-term survival of lung cancer? A population-based cohort study from French cancer registries
  48. Lung cancer risk and occupational exposures in crop farming: results from the AGRIculture and CANcer (AGRICAN) cohort
  49. Adolescent and young adult oncology patients in France: Heterogeneity in pathways of care
  50. Use of a case-mix approach to study the trends in the incidence of second primary cancers
  51. Occupational exposure to petroleum-based and oxygenated solvents and hypopharyngeal and laryngeal cancer in France: the ICARE study
  52. Merkel cell carcinoma in France: a registries‐based, comprehensive epidemiological survey
  53. Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries
  54. Trends in molecular subtypes of breast cancer: description of incidence rates between 2007 and 2012 from three French registries
  55. Occupational prestige trajectory and the risk of lung and head and neck cancer among men and women in France
  56. Erratum to “The histology of ovarian cancer: Worldwide distribution and implications for international survival comparisons (CONCORD-2)” [Gynecol. Oncol. 144 (2017) 405–413]
  57. Erratum to “Worldwide comparison of ovarian cancer survival: Histological group and stage at diagnosis (CONCORD-2)” [Gynecol. Oncol. 144 (2017) 396–404]
  58. Long-term trends in incidence and survival of penile cancer in France
  59. Burden and centralised treatment in Europe of rare tumours: results of RARECAREnet—a population-based study
  60. Neighborhood deprivation and risk of head and neck cancer: A multilevel analysis from France
  61. Central nervous system tumors and agricultural exposures in the prospective cohort AGRICAN
  62. Occupational exposure to chlorinated solvents and risk of head and neck cancer in men: a population-based case-control study in France
  63. Focus on an unusual rise in pancreatic cancer incidence in France
  64. International incidence of childhood cancer, 2001–10: a population-based registry study
  65. Occupational exposure to endotoxins and lung cancer risk: results of the ICARE Study
  66. Survival of 86,690 patients with thyroid cancer: A population-based study in 29 European countries from EUROCARE-5
  67. Worldwide comparison of survival from childhood leukaemia for 1995–2009, by subtype, age, and sex (CONCORD-2): a population-based study of individual data for 89 828 children from 198 registries in 53 countries
  68. Development of a model to predict the 10-year cumulative risk of second primary cancer among cancer survivors
  69. Oral cancer characteristics in France: Descriptive epidemiology for early detection
  70. The histology of ovarian cancer: worldwide distribution and implications for international survival comparisons (CONCORD-2)
  71. Worldwide comparison of ovarian cancer survival: Histological group and stage at diagnosis (CONCORD-2)
  72. Trends in net survival from kidney cancer in six European Latin countries
  73. Trends in net survival from breast cancer in six European Latin countries: results from the SUDCAN population-based study
  74. New insights into survival trend analyses in cancer population-based studies: the SUDCAN methodology
  75. Trends in net survival from 15 cancers in six European Latin countries: the SUDCAN population-based study material
  76. Trends in net survival from cervical cancer in six European Latin countries: results from the SUDCAN population-based study
  77. Trends in net survival from colon cancer in six European Latin countries: results from the SUDCAN population-based study
  78. Trends in net survival from corpus uteri cancer in six European Latin countries: results from the SUDCAN population-based study
  79. Trends in net survival from esophageal cancer in six European Latin countries: results from the SUDCAN population-based study
  80. Trends in net survival from head and neck cancer in six European Latin countries: results from the SUDCAN population-based study
  81. Trends in net survival from liver cancer in six European Latin countries: results from the SUDCAN population-based study
  82. Trends in net survival from ovarian cancer in six European Latin countries: results from the SUDCAN population-based study
  83. Trends in net survival from pancreatic cancer in six European Latin countries: results from the SUDCAN population-based study
  84. Trends in net survival from prostate cancer in six European Latin countries: results from the SUDCAN population-based study
  85. Trends in net survival from rectal cancer in six European Latin countries: results from the SUDCAN population-based study
  86. Trends in net survival from skin malignant melanoma in six European Latin countries: results from the SUDCAN population-based study
  87. Trends in net survival from stomach cancer in six European Latin countries: results from the SUDCAN population-based study
  88. Trends in net survival lung cancer in six European Latin countries: results from the SUDCAN population-based study
  89. Short-term and long-term survival of interval breast cancers taking into account prognostic features
  90. Breast cancer incidence: Decreasing trend in large tumours in women aged 50–74
  91. Are disparities of waiting times for breast cancer care related to socio‐economic factors? A regional population‐based study (France)
  92. Long-term quality of life among localised prostate cancer survivors: QALIPRO population-based study
  93. Quantifying the mediating effects of smoking and occupational exposures in the relation between education and lung cancer: the ICARE study
  94. Professional Cleaning Activities and Lung Cancer Risk Among Women
  95. Multidimensional analysis of the effect of occupational exposure to organic solvents on lung cancer risk: the ICARE study
  96. Welding, a risk factor of lung cancer: the ICARE study
  97. Ovarian cancer in France: Trends in incidence, mortality and survival, 1980–2012
  98. Population attributable risks of oral cavity cancer to behavioral and medical risk factors in France: results of a large population-based case–control study, the ICARE study
  99. The joint effect of asbestos exposure, tobacco smoking and alcohol drinking on laryngeal cancer risk: evidence from the French population-based case–control study, ICARE
  100. Global surveillance of cancer survival 1995–2009: analysis of individual data for 25 676 887 patients from 279 population-based registries in 67 countries (CONCORD-2)
  101. Occupation and head and neck cancer in women—Results of the ICARE study
  102. Trends in breast cancer incidence and mortality in France 1990–2008
  103. Management of rectal cancers in relation to treatment guidelines: a population-based study comparing Italian and French patients
  104. Management of rectal cancer in France in a well-defined population
  105. Association between Oestrogens Receptor Expressions in Breast Cancer and Comorbidities: A Cross-Sectional, Population-Based Study
  106. Cancer incidence and mortality in France over the 1980–2012 period: Solid tumors
  107. Cancer survival in Europe 1999–2007 by country and age: results of EUROCARE-5—a population-based study
  108. Methodological aspects of estimating rare cancer prevalence in Europe: The experience of the RARECARE project
  109. Are prognostic factors more favorable for breast cancer detected by organized screening than by opportunistic screening or clinical diagnosis? A study in Loire-Atlantique (France)
  110. Trends in incidence of breast cancer among women under 40 in seven European countries: A GRELL cooperative study
  111. Waiting time disparities in breast cancer diagnosis and treatment: A population-based study in France
  112. Consistency and inconsistency in testing biomarkers in breast cancer. A GRELL study in cut-off variability in the Romance language countries
  113. Life expectancy estimates as a key factor in over-treatment: The case of prostate cancer
  114. Risk of Lung Cancer Associated With Occupational Exposure to Mineral Wools
  115. Cancer Incidence and Survival in Adolescents and Young Adults in France, 2000–2008
  116. Unbiased estimates of long‐term net survival of solid cancers in France
  117. Éléments d’exhaustivité et résultats pour la première année d’enregistrement du Registre général des cancers de Lille et de sa région
  118. Cigarette smoking and lung cancer in women: Results of the French ICARE case–control study
  119. Investigation of occupational and environmental causes of respiratory cancers (ICARE): a multicenter, population-based case-control study in France
  120. Rare cancers are not so rare: The rare cancer burden in Europe
  121. Modelling the effect of breast cancer screening on related mortality using French data
  122. Occupations and industries in France at high risk for pleural mesothelioma: A population‐based case–control study (1998–2002)
  123. Breast cancer following radiotherapy for a hemangioma during childhood
  124. Recent trends in breast cancer incidence rates in the Loire-Atlantique, France: A decline since 2003
  125. Multi-state Markov models in cancer screening evaluation: a brief review and case study
  126. Descriptive epidemiology of thyroid cancer in France: Incidence, mortality and survival
  127. A population-based study of adjuvant chemotherapy for stage-II and -III colon cancers
  128. The Burden of Rare Cancers in Europe
  129. Le cancer de la prostate en France en 2001 : état des pratiques et facteurs associés à la réalisation d’une prostatectomie totale
  130. Disparités géographiques d’évolution d’incidence des cancers de la thyroïde par taille entre 1983 et 2000 en France
  131. Evolution of pleural cancers and malignant pleural mesothelioma incidence in France between 1980 and 2005
  132. EUROCARE-4. Survival of cancer patients diagnosed in 1995–1999. Results and commentary
  133. Comparative cancer survival information in Europe
  134. The cure of cancer: A European perspective
  135. Survival of European children and young adults with cancer diagnosed 1995–2002
  136. The EUROCARE-4 database on cancer survival in Europe: Data standardisation, quality control and methods of statistical analysis
  137. Long-term survival expectations of cancer patients in Europe in 2000–2002
  138. Multiple tumours in survival estimates
  139. Survival trends in European cancer patients diagnosed from 1988 to 1999
  140. The advantage of women in cancer survival: An analysis of EUROCARE-4 data
  141. The cancer survival gap between elderly and middle-aged patients in Europe is widening
  142. Cancer incidence and mortality in France over the period 1980–2005
  143. Is breast cancer incidence increasing among young women? An analysis of the trend in France for the period 1983–2002
  144. Trends in incidence of digestive cancers in France
  145. Incidence et facteurs pronostiques des cancers du sein découverts au cours et en dehors du programme de dépistage organisé en Loire-Atlantique (1991–2002)
  146. Cancer prevalence in France: Time trend, situation in 2002 and extrapolation to 2012
  147. A time trend analysis of papillary and follicular cancers as a function of tumour size: A study of data from six cancer registries in France (1983–2000)
  148. Survival of cancer patients in France: A population-based study from The Association of the French Cancer Registries (FRANCIM)
  149. Socioeconomic and geographic determinants of survival of patients with digestive cancer in France
  150. Valeur prédictive et sensibilité du programme de médicalisation des systèmes d’information (PMSI) par rapport aux registres des cancers : application au cancer de la thyroïde (1999-2000)
  151. Évolution de l’incidence du cancer broncho-pulmonaire en France (1978-2000)
  152. Incidence, Clinical Presentation and Location at Diagnosis of Pediatric Inflammatory Bowel Disease: A Prospective Population‐Based Study in Northern France (1988‐1999)
  153. Opposite evolution in incidence of Crohn's disease and ulcerative colitis in Northern France (1988-1999)
  154. Effects of lipid peroxidation and antioxidant status on peak flow in a population aged 59–71 years: the EVA study